Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.

Summary

The study was planned in 2 parts: Parts A and B. In Part A, we tested 2 single doses of the study medicine in healthy volunteers: 500 mg and 750 mg. Part B was an optional part to test once-daily doses of the study medicine in healthy volunteers. We aimed to assess the safety, tolerability find out the side effects and blood levels of the PXL770.

Timeline

Start

2021-03-08

Primary completion

2021-03-29

Completion

2021-03-29

Drugs

Indications